• PORTFOLIO
  • ABOUT US
  • TEAM
  • CHALLENGE NETWORK
  • INSIGHTS
  • PRESS
  • CONTACT
Clarevia Backs Milwaukee Biotech Company Sanacor to Address Cardiometabolic Disease

Clarevia Backs Milwaukee Biotech Company Sanacor to Address Cardiometabolic Disease

by Kayla Liederbach | May 9, 2025 | Portfolio Spotlights

Madison, WI — January 9, 2025 — Clarevia (VI), a Midwest-based venture capital firm dedicated to advancing transformative healthcare innovations, proudly announces its investment in Sanacor, Inc. (Sanacor), a biotechnology company focused on...
Clarevia Promotes Jenni Le to Principal, Expanding Commitment to University Spinouts and Healthcare Innovation

Clarevia Promotes Jenni Le to Principal, Expanding Commitment to University Spinouts and Healthcare Innovation

by Kayla Liederbach | May 5, 2025 | Firm News

Photo: Jenni Le speaking at Clarevia’ recent event, celebrating 30 years of investment in Third Wave Technologies, hosted at Exact Sciences in Madison. Madison, WI — December 19th, 2024 — Clarevia (VI), a Midwest-based venture capital firm focused on healthcare...
Next Entries »

Follow Us

  • Follow

Quick Links

Home

Portfolio

About Us
Team
Challenge Network
Insights
Press
Contact

Join the Clarevia Community!

indicates required
Copyright © 2026. Clarevia. All Rights Reserved.